> top > docs > PubMed:32307550 > annotations

PubMed:32307550 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-OGER-BB

Id Subject Object Predicate Lexical cue
T1 15-19 SO:0000704 denotes gene
T2 15-30 GO:0010467 denotes gene expression
T3 44-50 UBERON:0002405 denotes immune
T4 44-60 GO:0006955 denotes immune responses
T5 103-111 SP_7 denotes COVID-19
T6 158-169 NCBITaxon:11118 denotes coronavirus
T7 179-187 SP_7 denotes COVID-19
T8 199-246 SP_7 denotes severe acute respiratory syndrome coronavirus 2
T9 212-223 UBERON:0001004 denotes respiratory
T10 248-258 SP_7 denotes SARS-CoV-2
T11 328-334 CL:0000084 denotes T cell
T12 358-362 SO:0000704 denotes gene
T13 358-373 GO:0010467 denotes gene expression
T14 387-395 SP_7 denotes COVID-19
T15 480-488 SP_7 denotes COVID-19
T16 559-565 UBERON:0001969 denotes Plasma
T17 609-613 SO:0000704 denotes gene
T18 609-624 GO:0010467 denotes gene expression
T19 780-791 CL:0000775 denotes neutrophils
T20 811-829 PR:000005897 denotes C-reactive protein
T21 864-869 PR:000001471 denotes IL-10
T22 955-961 CL:0000084 denotes T cell
T23 991-999 SP_7 denotes COVID-19
T24 1113-1116 PR:000001004 denotes CD4
T25 1117-1124 CL:0000084 denotes T cells
T26 1313-1322 CL:0000899 denotes Th17 cell
T27 1318-1338 GO:0030154 denotes cell differentiation
T28 1340-1367 GO:0019221 denotes cytokine-mediated signaling
T29 1380-1386 CL:0000084 denotes T cell
T30 1380-1397 GO:0042110 denotes T cell activation
T31 1439-1445 PR:000010128 denotes MAP2K7
T32 1450-1454 PR:000015413 denotes SOS1
T33 1546-1552 CL:0000084 denotes T cell
T34 1584-1588 SO:0000704 denotes gene
T35 1584-1599 GO:0010467 denotes gene expression
T36 1611-1617 CL:0000084 denotes T cell
T37 1611-1628 GO:0042110 denotes T cell activation
T38 1666-1674 SP_7 denotes COVID-19
T39 1753-1761 SP_7 denotes COVID-19

sonoma2

Id Subject Object Predicate Lexical cue
T0 0-14 NEGREG denotes Down-regulated
T1 20-30 MPA denotes expression
T2 44-60 CPA denotes immune responses
T3 61-68 REG denotes changed
T5 103-111 DISEASE denotes COVID-19
T6 136-146 DISEASE denotes O characte
T7 148-156 DISEASE denotes zes nove
T9 1-9 DISEASE denotes own-regu
T10 189-195 REG denotes caused
T11 311-326 MPA denotes cytokine levels
T12 340-347 DISEASE denotes rtion a
T13 363-373 MPA denotes expression
T14 374-383 REG denotes occurring
T15 0-8 DISEASE denotes Down-reg
T16 427-434 DISEASE denotes intial
T17 480-488 DISEASE denotes COVID-19
T20 613-623 DISEASE denotes expressio
T21 614-624 MPA denotes expression
T22 663-678 GENE denotes severe patients
T23 694-699 DISEASE denotes Cough
T24 704-709 CPA denotes fever
T25 713-718 GENE denotes e the
T26 742-752 DISEASE denotes COVID-2019
T27 775-778 POSREG denotes mor
T29 804-810 POSREG denotes higher
T30 811-835 MPA denotes C-reactive protein level
T31 841-846 REG denotes found
T32 841-849 DISEASE denotes found in
T33 870-875 MPA denotes level
T34 894-900 REG denotes varied
T35 945-954 NEGREG denotes decreased
T36 955-973 CPA denotes T cell proportions
T37 971-976 GENE denotes ns we
T38 979-987 REG denotes observed
T39 0-8 DISEASE denotes Down-reg
T40 1025-1029 GENE denotes vere
T41 1105-1109 GENE denotes ut o
T42 1113-1124 CPA denotes CD4+T cells
T43 1173-1174 REG denotes D
T44 1174-1175 REG denotes E
T45 1178-1187 POSREG denotes increased
T46 1219-1228 NEGREG denotes decreased
T47 1232-1238 GENE denotes er ini
T48 1243-1247 GENE denotes trea
T49 1258-1272 NEGREG denotes down-regulated
T50 1301-1309 REG denotes involved
T51 1313-1338 CPA denotes Th17 cell differentiation
T52 1340-1375 PATHWAY denotes cytokine-mediated signaling pathway
T53 1380-1397 CPA denotes T cell activation
T54 1439-1445 GENE denotes MAP2K7
T55 1450-1454 GENE denotes SOS1
T56 1460-1471 POSREG denotes upregulated
T57 1460-1468 DISEASE denotes upregula
T58 1536-1545 NEGREG denotes decreased
T59 1541-1549 DISEASE denotes ased T c
T60 1546-1563 CPA denotes T cell proportion
T61 1569-1583 NEGREG denotes down-regulated
T62 1589-1599 MPA denotes expression
T63 1611-1628 CPA denotes T cell activation
T64 1633-1648 CPA denotes differentiation
T65 1654-1662 REG denotes occurred
T66 1666-1674 DISEASE denotes COVID-19
T67 1728-1737 CPA denotes treatment
T68 1753-1761 DISEASE denotes COVID-19
R21 T44 T43 ThemeOf E,D
R22 T44 T45 ThemeOf E,increased
R23 T51 T49 ThemeOf Th17 cell differentiation,down-regulated
R24 T51 T50 ThemeOf Th17 cell differentiation,involved
R25 T52 T50 ThemeOf cytokine-mediated signaling pathway,involved
R26 T53 T50 ThemeOf T cell activation,involved
R27 T54 T56 ThemeOf MAP2K7,upregulated
R28 T55 T56 ThemeOf SOS1,upregulated
R29 T58 T61 CauseOf decreased,down-regulated
R30 T60 T58 ThemeOf T cell proportion,decreased
R31 T60 T61 ThemeOf T cell proportion,down-regulated
R32 T60 T62 ThemeOf T cell proportion,expression
R0 T1 T0 ThemeOf expression,Down-regulated
R1 T1 T3 ThemeOf expression,changed
R2 T2 T0 ThemeOf immune responses,Down-regulated
R3 T2 T3 ThemeOf immune responses,changed
R4 T5 T3 ThemeOf COVID-19,changed
R6 T9 T10 ThemeOf own-regu,caused
R7 T11 T13 ThemeOf cytokine levels,expression
R8 T11 T14 ThemeOf cytokine levels,occurring
R9 T13 T14 ThemeOf expression,occurring
R10 T15 T13 ThemeOf Down-reg,expression
R11 T15 T14 ThemeOf Down-reg,occurring
R14 T30 T29 ThemeOf C-reactive protein level,higher
R15 T30 T31 ThemeOf C-reactive protein level,found
R16 T33 T34 ThemeOf level,varied
R17 T36 T35 ThemeOf T cell proportions,decreased
R18 T36 T38 ThemeOf T cell proportions,observed
R19 T39 T35 ThemeOf Down-reg,decreased
R20 T39 T38 ThemeOf Down-reg,observed
R33 T60 T65 ThemeOf T cell proportion,occurred
R34 T62 T61 ThemeOf expression,down-regulated
R35 T62 T58 ThemeOf expression,decreased
R36 T64 T62 ThemeOf differentiation,expression
R37 T62 T65 ThemeOf expression,occurred
R38 T63 T58 ThemeOf T cell activation,decreased
R39 T63 T61 ThemeOf T cell activation,down-regulated
R40 T63 T62 ThemeOf T cell activation,expression
R41 T63 T65 ThemeOf T cell activation,occurred
R42 T64 T58 ThemeOf differentiation,decreased
R43 T64 T61 ThemeOf differentiation,down-regulated
R44 T64 T65 ThemeOf differentiation,occurred
R45 T66 T58 ThemeOf COVID-19,decreased
R46 T66 T61 ThemeOf COVID-19,down-regulated
R47 T66 T65 ThemeOf COVID-19,occurred
R48 T68 T67 ThemeOf COVID-19,treatment